Literature DB >> 16596025

Are beta blockers passé for the treatment of hypertension?

Panteleimon A Sarafidis, George L Bakris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596025      PMCID: PMC8109535          DOI: 10.1111/j.1524-6175.2005.05152.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  13 in total

Review 1.  The hemodynamic effects of adrenergic blocking agents.

Authors:  P Lund-Johansen
Journal:  Cleve Clin J Med       Date:  1992 Mar-Apr       Impact factor: 2.321

Review 2.  Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Authors:  Lars Hjalmar Lindholm; Bo Carlberg; Ola Samuelsson
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

3.  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

Authors: 
Journal:  Arch Intern Med       Date:  1993-01-25

4.  Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

Authors:  George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Rosemary Oakes; Mary Ann Lukas; Karen M Anderson; David S H Bell
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

5.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

Review 6.  beta-Blockers in hypertension-the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension.

Authors:  Franz H Messerli; D Gareth Beevers; Stanley S Franklin; Thomas G Pickering
Journal:  Am J Hypertens       Date:  2003-10       Impact factor: 2.689

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 8.  Continued importance of diuretics and beta-adrenergic blockers in the management of hypertension.

Authors:  Marvin Moser; John Setaro
Journal:  Med Clin North Am       Date:  2004-01       Impact factor: 5.456

9.  Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

Authors:  F H Messerli; E Grossman; U Goldbourt
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

Review 10.  Cardioprotection: the role of beta-blocker therapy.

Authors:  Brent M Egan; Jan Basile; Robert J Chilton; Jerome D Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-07       Impact factor: 3.738

View more
  3 in total

Review 1.  Metabolic safety of antihypertensive drugs: myth versus reality.

Authors:  Sameer Stas; Lama Appesh; James Sowers
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

2.  Comparative efficacy of two different beta-blockers on 24-hour blood pressure control.

Authors:  Pantelis Sarafidis; Zvezdana Bogojevic; Emad Basta; Emily Kirstner; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

Review 3.  Carvedilol in hypertension treatment.

Authors:  Panagiotis C Stafylas; Pantelis A Sarafidis
Journal:  Vasc Health Risk Manag       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.